case_images: PMC6620858_01
case_images: Mediolateral oblique view of the right breast shows a rim of density surrounding the silicone implant (white arrow).
case_images: CRIRA2019-6137198.001.jpg
case_images: PMC6620858_01_CRIRA2019-6137198.001.jpg
case_images: fig1
case_images: On the mammography, the mediolateral oblique (MLO) view without compression demonstrates that the right prosthesis is deformed on its anterior surface (Figure 1).
case_images: Case 1, representative section of the cell block preparation from effusion fluid. (a) A cluster of lymphoma cells is observed (hematoxylin and eosin); (b) CD30 expression by the neoplastic cells of BIA-ALCL (original magnification 200x).
case_images: CRIRA2019-6137198.002.jpg
case_images: PMC6620858_01_CRIRA2019-6137198.002.jpg
case_images: fig2
case_images: The pathologic evaluation of the second part of this sample firstly reveals the presence of atypical cells (Figure 2(a)). Immunohistochemical analysis then demonstrated a moderate and diffused expression of CD30 (Figure 2(b)).
case_images: PMC6620858_02
case_images: Mediolateral oblique view of the left breast shows a rim of density surrounding the silicone implant (white arrow).
case_images: CRIRA2019-6137198.003.jpg
case_images: PMC6620858_02_CRIRA2019-6137198.003.jpg
case_images: fig3
case_images: On the mammography, the mediolateral oblique (MLO) view without compression demonstrates that the left prosthesis is deformed on its anterior pole and a periprosthetic collection developed mainly on the anterior surface of the prosthesis (Figure 3).
case_images: Ultrasound of the left breast demonstrates periprosthetic fluid reaction in the inner region (white arrow).
case_images: CRIRA2019-6137198.004.jpg
case_images: PMC6620858_02_CRIRA2019-6137198.004.jpg
case_images: fig4
case_images: But it confirmed the existence of a significant left periprosthetic fluid reaction predominant in the inner region (Figure 4).
case_images: Case 2, (a) H&E section of the cell block preparation from effusion fluid showing atypical lymphocytes; (b) CD30 immunohistochemistry highlights tumor cells positive for CD30 (original magnification 200x).
case_images: CRIRA2019-6137198.005.jpg
case_images: PMC6620858_02_CRIRA2019-6137198.005.jpg
case_images: fig5
case_images: The pathologic evaluation of the second part of this sample identified atypical cells (Figure 5(a)) and a positivity for CD30 (Figure 5(b)).